C12N 2760/18323
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2760/18323 (Virus like particles [vlp]) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 5
- Assignees
- 2
- Inventors
- 8
- Latest grant
- 1 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 1 |
| 2025 | 1 | 2 |
By publication year.
Recent patents
- Protein-based nanoparticle vaccine for metapneumovirus1 Jul 2025US 12,343,391 B2Icosavax, Inc.
- Protein-based nanoparticle vaccine for metapneumovirus7 Nov 2023US 11,806,394 B2Icosavax, Inc.
- Human respiratory syncytial virus (HRSV) virus-like particles (VLPS) based vaccine10 May 2022US 11,324,816 B2TechnoVax, Inc.
- Protein-based nanoparticle vaccine for metapneumovirus23 Oct 2025US 2025/0325651 A1Icosavax, Inc.
- Multivalent vaccine for paramyxoviruses and uses thereof22 May 2025US 2025/0161436 A1Icosavax, Inc.
- Protein-based nanoparticle vaccine for metapneumovirus4 Jul 2024US 2024/0216499 A1Icosavax, Inc.
- Protein-based nanoparticle vaccine for metapneumovirus3 Aug 2023US 2023/0241199 A1Icosavax, Inc.
- Human respiratory syncytial virus (hrsv) virus-like particles (vlps) based vaccine31 Jan 2019US 2019/0030156 A1TechnoVax, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.